Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 68

1.

Strictly co-isogenic C57BL/6J-Prnp-/- mice: A rigorous resource for prion science.

Nuvolone M, Hermann M, Sorce S, Russo G, Tiberi C, Schwarz P, Minikel E, Sanoudou D, Pelczar P, Aguzzi A.

J Exp Med. 2016 Mar 7;213(3):313-27. doi: 10.1084/jem.20151610. Epub 2016 Feb 29.

PMID:
26926995
2.

Genetic modifiers to the PLN L39X mutation in a patient with DCM and sustained ventricular tachycardia?

Sanoudou D, Kolokathis F, Arvanitis D, Al-Shafai K, Krishnamoorthy N, Buchan RJ, Walsh R, Tsiapras D, Barton PJ, Cook SA, Kremastinos D, Yacoub M.

Glob Cardiol Sci Pract. 2015 Jul 3;2015(2):29. doi: 10.5339/gcsp.2015.29. eCollection 2015. No abstract available.

3.

Human G109E-inhibitor-1 impairs cardiac function and promotes arrhythmias.

Haghighi K, Pritchard TJ, Liu GS, Singh VP, Bidwell P, Lam CK, Vafiadaki E, Das P, Ma J, Kunduri S, Sanoudou D, Florea S, Vanderbilt E, Wang HS, Rubinstein J, Hajjar RJ, Kranias EG.

J Mol Cell Cardiol. 2015 Dec;89(Pt B):349-59. doi: 10.1016/j.yjmcc.2015.10.004. Epub 2015 Oct 9.

PMID:
26455482
4.

Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies.

Bourdenx M, Koulakiotis NS, Sanoudou D, Bezard E, Dehay B, Tsarbopoulos A.

Prog Neurobiol. 2015 Jul 21. pii: S0301-0082(15)00077-5. doi: 10.1016/j.pneurobio.2015.07.003. [Epub ahead of print]

PMID:
26209472
5.

Muscle LIM Protein: Master regulator of cardiac and skeletal muscle functions.

Vafiadaki E, Arvanitis DA, Sanoudou D.

Gene. 2015 Jul 15;566(1):1-7. doi: 10.1016/j.gene.2015.04.077. Epub 2015 Apr 30. Review.

PMID:
25936993
6.

Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy.

Karakikes I, Stillitano F, Nonnenmacher M, Tzimas C, Sanoudou D, Termglinchan V, Kong CW, Rushing S, Hansen J, Ceholski D, Kolokathis F, Kremastinos D, Katoulis A, Ren L, Cohen N, Gho JM, Tsiapras D, Vink A, Wu JC, Asselbergs FW, Li RA, Hulot JS, Kranias EG, Hajjar RJ.

Nat Commun. 2015 Apr 29;6:6955. doi: 10.1038/ncomms7955.

7.

Cardioprotection by H2S engages a cGMP-dependent protein kinase G/phospholamban pathway.

Bibli SI, Andreadou I, Chatzianastasiou A, Tzimas C, Sanoudou D, Kranias E, Brouckaert P, Coletta C, Szabo C, Kremastinos DT, Iliodromitis EK, Papapetropoulos A.

Cardiovasc Res. 2015 Jun 1;106(3):432-42. doi: 10.1093/cvr/cvv129. Epub 2015 Apr 13.

PMID:
25870184
8.

Calcium/calmodulin-dependent protein kinase II (CaMKII) inhibition ameliorates arrhythmias elicited by junctin ablation under stress conditions.

Tzimas C, Terrovitis J, Lehnart SE, Kranias EG, Sanoudou D.

Heart Rhythm. 2015 Jul;12(7):1599-610. doi: 10.1016/j.hrthm.2015.03.043. Epub 2015 Mar 23.

PMID:
25814413
9.

Prion infections and anti-PrP antibodies trigger converging neurotoxic pathways.

Herrmann US, Sonati T, Falsig J, Reimann RR, Dametto P, O'Connor T, Li B, Lau A, Hornemann S, Sorce S, Wagner U, Sanoudou D, Aguzzi A.

PLoS Pathog. 2015 Feb 24;11(2):e1004662. doi: 10.1371/journal.ppat.1004662. eCollection 2015 Feb. Erratum in: PLoS Pathog. 2015 Apr;11(4):e1004808.

10.

Outpatient management of chronic heart failure.

Kaldara E, Sanoudou D, Adamopoulos S, Nanas JN.

Expert Opin Pharmacother. 2015 Jan;16(1):17-41. doi: 10.1517/14656566.2015.978286. Epub 2014 Dec 5. Review.

PMID:
25480690
11.

MicroRNAs in heart failure: Small molecules with major impact.

Kalozoumi G, Yacoub M, Sanoudou D.

Glob Cardiol Sci Pract. 2014 Jun 18;2014(2):79-102. doi: 10.5339/gcsp.2014.30. eCollection 2014. Review.

12.

Pharmacogenomics in the development and characterization of atheroprotective drugs.

Valanti E, Tsompanidis A, Sanoudou D.

Methods Mol Biol. 2014;1175:259-300. doi: 10.1007/978-1-4939-0956-8_11. Review.

PMID:
25150873
13.

Muscle lim protein isoform negatively regulates striated muscle actin dynamics and differentiation.

Vafiadaki E, Arvanitis DA, Papalouka V, Terzis G, Roumeliotis TI, Spengos K, Garbis SD, Manta P, Kranias EG, Sanoudou D.

FEBS J. 2014 Jul;281(14):3261-79. doi: 10.1111/febs.12859. Epub 2014 Jun 11.

14.

Forced swim test induces divergent global transcriptomic alterations in the hippocampus of high versus low novelty-seeker rats.

Pitychoutis PM, Sanoudou D, Papandreou M, Nasias D, Kouskou M, Tomlinson CR, Tsonis PA, Papadopoulou-Daifoti Z.

Hum Genomics. 2014 Feb 25;8:4. doi: 10.1186/1479-7364-8-4.

15.

Identification of a protein phosphatase-1/phospholamban complex that is regulated by cAMP-dependent phosphorylation.

Vafiadaki E, Arvanitis DA, Sanoudou D, Kranias EG.

PLoS One. 2013 Nov 14;8(11):e80867. doi: 10.1371/journal.pone.0080867. eCollection 2013.

16.

Pharmacogenetic considerations for late life depression therapy.

Pitychoutis PM, Kokras N, Sanoudou D, Dalla C, Papadopoulou-Daifoti Z.

Expert Opin Drug Metab Toxicol. 2013 Aug;9(8):989-99. doi: 10.1517/17425255.2013.794786. Epub 2013 May 4. Review.

PMID:
23641676
17.

Reprogramming of the microRNA transcriptome mediates resistance to rapamycin.

Totary-Jain H, Sanoudou D, Ben-Dov IZ, Dautriche CN, Guarnieri P, Marx SO, Tuschl T, Marks AR.

J Biol Chem. 2013 Mar 1;288(9):6034-44. doi: 10.1074/jbc.M112.416446. Epub 2013 Jan 8.

18.

Science and practice of arrhythmogenic cardiomyopathy: A paradigm shift.

Elmaghawry M, Migliore F, Mohammed N, Sanoudou D, Alhashemi M.

Glob Cardiol Sci Pract. 2013 Nov 1;2013(1):63-79. doi: 10.5339/gcsp.2013.8. eCollection 2013. Review. No abstract available.

19.
20.

Rapamycin resistance is linked to defective regulation of Skp2.

Totary-Jain H, Sanoudou D, Dautriche CN, Schneller H, Zambrana L, Marks AR.

Cancer Res. 2012 Apr 1;72(7):1836-43. doi: 10.1158/0008-5472.CAN-11-2195. Epub 2012 Feb 6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk